Author: ksvirus

On behalf of the KSHV ASSOCIATION, we congratulate the following trainees (graduate students, postdocs, and pre-doctoral study technicians working in academic or government labs).

Late-Breaking Abstract Submission Deadline is 10 June!View the interactive, online final program here. Online abstract submission for the Late-Breaking Session and Poster Sessions is now open!The opening day will feature a session focused on current clinical and translational challenges in the field, underscoring the importance of linking basic and patient-oriented research

We warmly invite participants to submit abstracts for oral or poster presentations before the March 16th submission deadline. In keeping with the Workshop’s interactive and collaborative spirit, the presentation of unpublished and emerging research is especially encouraged. The Workshop has long been recognized as an excellent opportunity for trainees at all levels to present their work, build networks, and engage with senior scientists and clinicians. There will be no invited speakers or lectures; all submitted contributions will be equally considered by the Scientific Advisory Committee (SAC).

Trainee Abstract Awards Application with the Online Abstract Submission – 16 March!
On behalf of the KAPOSI’S SARCOMA HERPESVIRUS (KSHV) AND RELATED AGENTS ASSOCIATION, we look forward to awarding a number of abstract award registration fee waivers for qualifying trainees (graduate students, postdocs and pre-doctoral study technicians working in academic or government labs).

Join the newly formed Kaposi’s Sarcoma Herpesvirus (KSHV) and Related Agents Association, Inc., an international non-profit organization (501 c 3 application pending), established for the purpose of promoting research related to KSHV, a cancer-causing herpesvirus, and related viruses by bringing researchers together once a year to share developments leading to discovery of new and better approaches for treating and preventing malignancies or lymphoproliferative disorders, including Kaposi’s sarcoma, pleural effusion lymphoma, multicentric Castleman’s disease, and an inflammatory disorder, KSHV-inflammatory cytokine syndrome (KICS).